Cargando…

The immune regulation of BCL3 in glioblastoma with mutated IDH1

Background: Glioblastoma in the brain is the most malignant solid tumor with a poor prognosis. Screening critical targets and exploring underlying mechanisms will be a benefit for diagnoses and treatment. IDH1 mutation (R132) was used to distinguish glioblastoma grade and predict prognosis as a sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Shibing, Wu, Na, Chang, Shichuan, Chen, Long, Sun, Xiaochuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134951/
https://www.ncbi.nlm.nih.gov/pubmed/35488886
http://dx.doi.org/10.18632/aging.204048

Ejemplares similares